FDA
-
-
-
-
-
-
-
NewLink Genetics (NLNK) Confirms FDA Approval of ERVEBO
-
-
-
-
-
-
-
NewLink Genetics Reports Third Quarter 2019 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
NewLink Genetics and Lumos Pharma Enter into Merger Agreement to Form Biopharmaceutical Company Focused on Developing Therapies to Treat Rare Diseases
-
-
-
-
-
-
-
NewLink Genetics Reports First Quarter 2019 Financial Results and Provides Clinical Activities Update
-
-
-
-
-
-
-
NewLink Genetics Announces Merck Has Begun Rolling Submission of Licensure Application for Ebola vaccine V920 (rVSV∆G-ZEBOV-GP) to U.S. Food and Drug Administration
-
-
-
-
-
-
-
NewLink Genetics (NLNK) Granted FDA Orphan-Drug Designation for Indoximod
-
-
-
-
-
-
-
Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

